FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066680949> ?p ?o ?g. }

• W2066680949 endingPage "2327" @default.
• W2066680949 startingPage "2315" @default.
• W2066680949 abstract "Abstract Recently, treatment with bromodomain and extraterminal protein antagonist (BA) such as JQ1 has been shown to inhibit growth and induce apoptosis of human acute myelogenous leukemia (AML) cells, including those expressing FLT3-ITD. Here, we demonstrate that cotreatment with JQ1 and the FLT3 tyrosine kinase inhibitor (TKI) ponatinib or AC220 synergistically induce apoptosis of cultured and primary CD34+ human AML blast progenitor cells (BPC) expressing FLT3-ITD. Concomitantly, as compared with each agent alone, cotreatment with JQ1 and the FLT3-TKI caused greater attenuation of c-MYC, BCL2, and CDK4/6. Simultaneously, cotreatment with JQ1 and the FLT3-TKI increased the levels of p21, BIM, and cleaved PARP, as well as mediated marked attenuation of p-STAT5, p-AKT, and p-ERK1/2 levels in AML BPCs. Conversely, cotreatment with JQ1 and FLT3-TKI was significantly less active against CD34+ normal bone marrow progenitor cells. Knockdown of BRD4 by short hairpin RNA also sensitized AML cells to FLT3-TKI. JQ1 treatment induced apoptosis of mouse Ba/F3 cells ectopically expressing FLT3-ITD with or without FLT3-TKI–resistant mutations F691L and D835V. Compared with the parental human AML FLT3-ITD–expressing MOLM13, MOLM13-TKIR cells resistant to AC220 were markedly more sensitive to JQ1-induced apoptosis. Furthermore, cotreatment with JQ1 and the pan-histone deacetylase inhibitor (HDI) panobinostat synergistically induced apoptosis of FLT3-TKI–resistant MOLM13-TKIR and MV4-11-TKIR cells. Collectively, these findings support the rationale for determining the in vivo activity of combined therapy with BA and FLT3-TKI against human AML cells expressing FLT3-ITD or with BA and HDI against AML cells resistant to FLT3-TKI. Mol Cancer Ther; 13(10); 2315–27. ©2014 AACR." @default.
• W2066680949 created "2016-06-24" @default.
• W2066680949 creator A5010972843 @default.
• W2066680949 creator A5016734314 @default.
• W2066680949 creator A5021235748 @default.
• W2066680949 creator A5044306916 @default.
• W2066680949 creator A5055171890 @default.
• W2066680949 creator A5061012285 @default.
• W2066680949 creator A5067678169 @default.
• W2066680949 creator A5072926885 @default.
• W2066680949 creator A5079069209 @default.
• W2066680949 creator A5091446214 @default.
• W2066680949 date "2014-10-01" @default.
• W2066680949 modified "2023-10-03" @default.
• W2066680949 title "BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD" @default.
• W2066680949 cites W1967269645 @default.
• W2066680949 cites W1967358345 @default.
• W2066680949 cites W1973537479 @default.
• W2066680949 cites W1974306958 @default.
• W2066680949 cites W1976033223 @default.
• W2066680949 cites W1981811959 @default.
• W2066680949 cites W1984209370 @default.
• W2066680949 cites W1984712646 @default.
• W2066680949 cites W1985877500 @default.
• W2066680949 cites W2000596495 @default.
• W2066680949 cites W2001777678 @default.
• W2066680949 cites W2001799880 @default.
• W2066680949 cites W2001854096 @default.
• W2066680949 cites W2002395443 @default.
• W2066680949 cites W2005691176 @default.
• W2066680949 cites W2007351520 @default.
• W2066680949 cites W2007812119 @default.
• W2066680949 cites W2008001245 @default.
• W2066680949 cites W2009478222 @default.
• W2066680949 cites W2009949436 @default.
• W2066680949 cites W2037548653 @default.
• W2066680949 cites W2041535798 @default.
• W2066680949 cites W2044308376 @default.
• W2066680949 cites W2047790609 @default.
• W2066680949 cites W2048811029 @default.
• W2066680949 cites W2048964430 @default.
• W2066680949 cites W2051815726 @default.
• W2066680949 cites W2056465113 @default.
• W2066680949 cites W2058943350 @default.
• W2066680949 cites W2060484997 @default.
• W2066680949 cites W2069849780 @default.
• W2066680949 cites W2069931679 @default.
• W2066680949 cites W2072898686 @default.
• W2066680949 cites W2076031927 @default.
• W2066680949 cites W2076333986 @default.
• W2066680949 cites W2077945404 @default.
• W2066680949 cites W2082117339 @default.
• W2066680949 cites W2088307815 @default.
• W2066680949 cites W2088947217 @default.
• W2066680949 cites W2095013649 @default.
• W2066680949 cites W2111815169 @default.
• W2066680949 cites W2120572492 @default.
• W2066680949 cites W2129129812 @default.
• W2066680949 cites W2131138683 @default.
• W2066680949 cites W2137465688 @default.
• W2066680949 cites W2147338626 @default.
• W2066680949 cites W2152981209 @default.
• W2066680949 cites W2169287961 @default.
• W2066680949 cites W2170419109 @default.
• W2066680949 doi "https://doi.org/10.1158/1535-7163.mct-14-0258" @default.
• W2066680949 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4185220" @default.
• W2066680949 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25053825" @default.
• W2066680949 hasPublicationYear "2014" @default.
• W2066680949 type Work @default.
• W2066680949 sameAs 2066680949 @default.
• W2066680949 citedByCount "124" @default.
• W2066680949 countsByYear W20666809492014 @default.
• W2066680949 countsByYear W20666809492015 @default.
• W2066680949 countsByYear W20666809492016 @default.
• W2066680949 countsByYear W20666809492017 @default.
• W2066680949 countsByYear W20666809492018 @default.
• W2066680949 countsByYear W20666809492019 @default.
• W2066680949 countsByYear W20666809492020 @default.
• W2066680949 countsByYear W20666809492021 @default.
• W2066680949 countsByYear W20666809492022 @default.
• W2066680949 countsByYear W20666809492023 @default.
• W2066680949 crossrefType "journal-article" @default.
• W2066680949 hasAuthorship W2066680949A5010972843 @default.
• W2066680949 hasAuthorship W2066680949A5016734314 @default.
• W2066680949 hasAuthorship W2066680949A5021235748 @default.
• W2066680949 hasAuthorship W2066680949A5044306916 @default.
• W2066680949 hasAuthorship W2066680949A5055171890 @default.
• W2066680949 hasAuthorship W2066680949A5061012285 @default.
• W2066680949 hasAuthorship W2066680949A5067678169 @default.
• W2066680949 hasAuthorship W2066680949A5072926885 @default.
• W2066680949 hasAuthorship W2066680949A5079069209 @default.
• W2066680949 hasAuthorship W2066680949A5091446214 @default.
• W2066680949 hasBestOaLocation W20666809491 @default.
• W2066680949 hasConcept C104317684 @default.
• W2066680949 hasConcept C109159458 @default.
• W2066680949 hasConcept C121608353 @default.
• W2066680949 hasConcept C126322002 @default.
• W2066680949 hasConcept C190283241 @default.

• next